Essential role of insulin-like growth factor 2 in resistance to histone deacetylase inhibitors

Activation of insulin-like growth factor receptor signaling mediates resistance to histone deacetylase inhibitors

(2015) Jin-Soo Kim et al.   CANCER LETTERS

Targeting the insulin-like growth factor receptor and Src signaling network for the treatment of non-small cell lung cancer

(2015) Hye-Young Min et al.   Molecular Cancer

STAT3-mediated IGF-2 secretion in the tumour microenvironment elicits innate resistance to anti-IGF-1R antibody

(2015) Ji-Sun Lee et al.   Nature Communications

A phase 1 clinical trial of vorinostat in combination with decitabine in patients with acute myeloid leukaemia or myelodysplastic syndrome

(2014) Mark Kirschbaum et al.   BRITISH JOURNAL OF HAEMATOLOGY

Transcriptional and posttranslational regulation of insulin-like growth factor binding protein-3 by Akt3

(2014) Quanri Jin et al.   CARCINOGENESIS

Epigenetic regulation of theIgf2/H19gene cluster

(2014) M. Nordin et al.   CELL PROLIFERATION

The stem cell transcription factor ZFP57 induces IGF2 expression to promote anchorage-independent growth in cancer cells

(2014) Y Tada et al.   ONCOGENE

Immunomodulatory Effects of Histone Deacetylase Inhibitors

(2013) P.V. Licciardi et al.   CURRENT MOLECULAR MEDICINE

Combating Resistance to Anti-IGFR Antibody by Targeting the Integrin β 3-Src Pathway

(2013) Dong Hoon Shin et al.   JNCI-Journal of the National Cancer Institute

JASPAR 2014: an extensively expanded and updated open-access database of transcription factor binding profiles

(2013) Anthony Mathelier et al.   NUCLEIC ACIDS RESEARCH

Evidence that Igf2 down-regulation in postnatal tissues and up-regulation in malignancies is driven by transcription factor E2f3

(2013) J. C. Lui et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Nanog regulates self-renewal of cancer stem cells through the insulin-like growth factor pathway in human hepatocellular carcinoma

(2012) Juanjuan Shan et al.   HEPATOLOGY

Insulin-like Growth Factor Receptor Inhibitors: Baby or the Bathwater?

(2012) D. Yee   JNCI-Journal of the National Cancer Institute

NIH Image to ImageJ: 25 years of image analysis

(2012) Caroline A Schneider et al.   NATURE METHODS

Acetylated STAT3 is crucial for methylation of tumor-suppressor gene promoters and inhibition by resveratrol results in demethylation

(2012) H. Lee et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Akt/mTOR Counteract the Antitumor Activities of Cixutumumab, an Anti-Insulin-like Growth Factor I Receptor Monoclonal Antibody

(2011) D. H. Shin et al.   MOLECULAR CANCER THERAPEUTICS

Acquired Resistance to BRAF Inhibitors Mediated by a RAF Kinase Switch in Melanoma Can Be Overcome by Cotargeting MEK and IGF-1R/PI3K

(2010) Jessie Villanueva et al.   CANCER CELL

Insulin-like Growth Factor 2 Expression Modulates Taxol Resistance and Is a Candidate Biomarker for Reduced Disease-Free Survival in Ovarian Cancer

(2010) G. S. Huang et al.   CLINICAL CANCER RESEARCH

Vorinostat (NSC# 701852) in Patients with Relapsed Non-small Cell Lung Cancer: A Wisconsin Oncology Network Phase II Study

(2010) Anne M. Traynor et al.   Journal of Thoracic Oncology

Hyperactivation of the Insulin-like Growth Factor Receptor I Signaling Pathway Is an Essential Event for Cisplatin Resistance of Ovarian Cancer Cells

(2009) N. Eckstein et al.   CANCER RESEARCH

Chemoresistant Colorectal Cancer Cells, the Cancer Stem Cell Phenotype, and Increased Sensitivity to Insulin-like Growth Factor-I Receptor Inhibition

(2009) N. A. Dallas et al.   CANCER RESEARCH

CTCF: Master Weaver of the Genome

(2009) Jennifer E. Phillips et al.   CELL

Hypoglycemia fromIGF2Overexpression Associated with Activation of Fetal Promoters and Loss of Imprinting in a Metastatic Hemangiopericytoma

(2009) Elizabeth A. Lawson et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Constitutive Activation of Signal Transducers and Activators of Transcription Predicts Vorinostat Resistance in Cutaneous T-Cell Lymphoma

(2008) V. R. Fantin et al.   CANCER RESEARCH

JAK2/STAT2/STAT3 Are Required for Myogenic Differentiation

(2008) Kepeng Wang et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Epitope tagging of endogenous proteins for genome-wide ChIP-chip studies

(2008) Xiaodong Zhang et al.   NATURE METHODS